Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
Titel:
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
Auteur:
Bodor, J. Nicholas Patel, Jyoti D. Wakelee, Heather A. Levy, Benjamin P. Borghaei, Hossein Pellini, Bruna Costello, Michael R. Dowell, Jonathan E. Finley, Gene Huang, Chao H. Neal, Joel W. Nieva, Jorge J Puri, Sonam Socinski, Mark A. Thomas, Christian Ross, Eric A. Litwin, Samuel Clapper, Margie L. Treat, Joseph